Pioneering DNA Innovator Dr. Martin Schleef Wins NRW Innovation Award 2025

The founder and long-standing CEO of PlasmidFactory GmbH, Dr. Martin Schleef, was honored in Düsseldorf with the Innovation Award 2025 of the State ...

September 11, 2025 | Thursday | News
Booking Health Expands Access to Dendritic Cell Immunotherapy for Recurrent Glioblastoma as New Clinical Data Confirm Survival Gains

Booking Health, a global medical travel platform, announced the expansion of patient access to dendritic cell immunotherapy for recurrent glioblastoma, f...

September 10, 2025 | Wednesday | News
Andelyn Biosciences Partners with Tern Therapeutics to Advance Late-Stage Manufacturing of Gene Therapy for CLN2 Batten Disease

Andelyn Biosciences, Inc., a pioneering and patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has partnered...

September 05, 2025 | Friday | News
Cayman Chemical and Curapath Partner to Deliver PEG-Free Shielding Lipids for Next-Generation LNP Therapies

Two leaders in lipid nanoparticle (LNP) development have partnered to make PEG-free shielding lipids available to researchers advancing LNPs for non-vira...

September 04, 2025 | Thursday | News
Wugen Secures $115 Million Financing to Advance Pivotal Trial of First-in-Class Allogeneic CAR-T Therapy

Financing led by Fidelity Management & Research Company with participation from RiverVest Venture Partners, Lightchain Capital, LYZZ Capital, Abingw...

August 28, 2025 | Thursday | News
Scenic Biotech Enters Research Collaboration with Alnylam to Discover Novel RNAi Targets Using Cell-Seq Platform

Scenic Biotech, a pioneer in modifier therapies for severe diseases, announced a license and research agreement with Alnylam Pharmaceuticals, Inc. (NASDA...

August 27, 2025 | Wednesday | News
XtalPi and Dong-A ST Sign MOU to Co-Develop Next-Generation Therapies for Immunology and Inflammation

XtalPi announced on the 20th that it signed a Memorandum of Understanding (MOU) with Korea's leading pharmaceutical company Dong-A ST, to jointly develop...

August 20, 2025 | Wednesday | News
Qihan Biotech Receives FDA Clearance to Begin U.S. Trial of Universal CAR-T Therapy for Refractory Lupus

Hangzhou Qihan Biotech Co., Ltd. ("Qihan" or "Qihan Biotech" or "the Company"), an industry leader in applying multiplexable genome editing technology to...

August 19, 2025 | Tuesday | News
Sarepta Advances SRP-1003 for DM1 Triggering $100 Million Milestone Payment to Arrowhead

Safety review leading to dose escalation and achievement of first predetermined enrollment target in Phase 1/2 study of SRP-1003 for DM1 triggers $100 ...

August 14, 2025 | Thursday | News
Bionova Scientific Opens Texas pDNA Facility to Advance Cell and Gene Therapy Manufacturing

Bionova Scientific®, a full-service biologics contract development and manufacturing organization (CDMO) and subsidiary of global conglomerate Asahi ...

August 13, 2025 | Wednesday | News
Sartorius and Nanotein Forge Strategic Alliance to Advance Immune Cell Manufacturing

Nanotein’s NanoSpark® reagents enhance cell activation and expansion in cell therapy manufacturing Exclusive global distribution agreement...

August 12, 2025 | Tuesday | News
Bristol Myers Squibb’s Breyanzi Granted FDA Priority Review for Relapsed or Refractory Marginal Zone Lymphoma

Breyanzi has the potential to be the first and only CAR T cell therapy approved for MZL, addressing a high unmet need Application based on results fro...

August 05, 2025 | Tuesday | News
BriaCell and BriaPro Unveil TILsRx Platform to Advance Next-Generation Multivalent Immunotherapies for Cancer

BriaCell Therapeutics Corp. a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care, and its majority owned s...

July 30, 2025 | Wednesday | News
Phlow and Antheia Forge Strategic Partnership to Onshore U.S. Pharmaceutical Supply Chains

Phlow Corp., a leading American pharmaceutical contract development and manufacturing organization (CDMO), and Antheia, the pharmaceutical ingredient man...

July 30, 2025 | Wednesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close